Revisiting 'intensive' blood glucose control: A causal directed acyclic graph-guided systematic review of randomized controlled trials.
Chi-Jung HuangWei-Ting WangShih-Hsien SungChen-Huan ChenGregory Y H LipBabangida S ChoriChern-En ChiangPublished in: Diabetes, obesity & metabolism (2022)
The main benefits of antidiabetic agents might result from the reduction in blood sugar levels and are generally independent of drugs used. Risk reduction in MACE was proportional to the magnitude of HbA1c decrease conferred by antidiabetic agents with less hypoglycaemic hazard.